Porphysome Foundry
The Porphysome Foundry is a pre-formation stage company at the Princess Margaret Cancer Centre (Toronto, Canada) focused on the development of porphyrin-based nanomedicines. Our technologies address key limitations in the visualization and focal treatment of solid tumours and metastatic disease during cancer surgeries in the lung, prostate, head and neck, and female reproductive tract. We are currently working towards a CTA/IND submission by Winter 2021, followed by clinical testing of our lead product in Phase I/II trials in Summer 2021.
Primary Contact: michael.valic@porphysome.ca